Dov Pharmaceutical dovpharm.com


Public list: Pharma Startups (4743) Neuroscience Startups (947)

focuses on novel drug candidates for central nervous system and other disorders, including cardiovascular and urological, that involve alterations in neuronal processing. Insomnia, pain and anxiolytic products have demonstrated efficacy in clinical trials. Other product candidates address the treatment of depression, angina and hypertension.

focuses on novel drug candidates for central nervous system and other disorders, including cardiovascular and urological, that involve alterations in neuronal processing. Insomnia, pain and anxiolytic products have demonstrated efficacy in clinical t...Show all

Company (IPO / Went public)

Phone: 732-907-3600

Fax:

150 Pierce Street

Somerset, 08873
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Dov Pharmaceutical $35.5M Apr 21, 2004
Cardioxyl Pharmaceuticals $66.6M Nov 2, 2015
Orexigen Therapeutics $160M Apr 23, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Dov Pharmaceutical Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders Feb 03, 2012 Jun 11, 2013 Patent
Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use Nov 06, 2007 Mar 20, 2012 Patent